Discover the latest content that has just been published on Research Tree
Companies: COG DOTD XSG XSG
Cambridge Cognition provided a positive FY 2021 trading update, with revenues (+50%) in line with expectations, net profit of £0.5m (FC £0.1m est) and year-end cash of £6.8m (FC £7.0m est). After a year of record order intake (£15.7m, +24%) and with a year-end order book of £17.0m (+52% on the prior year), the company is well positioned for FY 2022, with visibility at this early stage in the year on c.69% of FY 2022 revenue forecasts. This update provides further evidence of (i) the demand for v
Companies: Cambridge Cognition Holdings Plc
Cambridge Cognition has released a 2021 trading update which shows the company had a strong year, with revenue for the period increasing 51% YoY and the order book growing 52% YoY. The company beat DCe's forecasts at the PAT level and was in-line on revenue and cash. The robust demand for virtual clinical trials, which increased due to the pandemic, is expected to continue into 2022. We have updated our forecasts, with EBITDA now higher at £0.5m (£0.3m) in 2021 and for 2022 at £0.5m (£0.4m), whi
Joiners: East Star Resources (EST.L) the Kazakhstan-focused gold and copper explorer, has raised gross proceeds of £3.1m by way of an oversubscribed placing and subscription of 62,000,000 new shares at a price of 5p, and has today been readmitted to the Official List of the Financial Conduct Authority by way of a Standard Listing following its acquisition of 100% of the share capital of Discovery Ventures Kazakhstan Limited, which holds an initial package of four licences in two producing but un
Companies: TAVI COG CUSN FEN GTLY NSCI LND EME
Companies: BOOM COG CHAR FEN IOG IQG ITX QTX
Companies: COG IDEA PPC RBN
Companies: Cambridge Cognition Holdings Plc (COG:LON)Tremor International Ltd. (TRMR:LON)
Interim results to 30 June 2021 were in line with the trading update issued on 3 August, which resulted in upgrades to our forecasts and target price. On the back of a 50% (£1.5m) rise in revenues to £4.5m, adjusted EBITDA increased £0.5m to £0.2m, illustrating the operational leverage of 80% gross margin software & services. Period-end cash increased 38% (+£1.2m) in the period to£ 4.2m. Cambridge Cognition is well positioned to be a long-term beneficiary of the trend of running virtual decentra
Cambridge Cognition has announced strong interims which are consistent with our recently upgraded forecasts. Revenue increased 50% YoY, which outstripped growth in admin expenses leading the group to swing to a net profit. Demand for the company's software & services to support clinical trials continues to be strong, with a contracted order book of £15.2m at the end of H1 21 (+36% HOH; +105% YoY). Contract prepayments aided strong cash generation which led net cash to increase +37% versus FY20 Y
Cambridge Cognition has released a very encouraging H1 update which was well ahead of our forecasts and we have upgraded our FY21 revenue estimate by +19%. Order intake in the period leapt +74% to £8.6m (H1 2020: £4.9m), including £6.4m of previously-announced large orders, including two very significant wins totalling £3.6m. H1 revenues rose +50% to £4.5m, well ahead of DCe £3.8m and the group delivered Adjusted EBITDA of £0.2m vs DCe breakeven. Customer prepayments from contracts resulted in a
Companies: AGY ARB BLV COG EOG FTC FLO
A positive trading update for H1 2021 prompts full-year upgrades to forecasts and provides the basis for the introduction of FY 2022 forecasts. H1 2021 sales orders increased 74% to £8.6m; up from £4.9m in H1 2020, with a 50% increase in revenues and a £0.5m increase in adjusted EBITDA to £0.2m. A record contracted order backlog (up 36% or £4.0m from 31 December 2020 to £15.2m), which contains several large contracts with revenues to be recognised over up to six years, provides improved long-ter
Companies: COG PMG EVG ORPH
Research Tree provides access to ongoing research coverage, media content and regulatory news on Cambridge Cognition Holdings Plc. We currently have 160 research reports from 6 professional analysts.
Joiners: No Joiners Today. Leavers: Rutherford Health has left the AQSE and Prime People has left AIM. What’s cooking in the IPO kitchen? ACP Energy plc, a company formed for the purpose of undertaking an acquisition or acquisitions of a majority interest in a company, business or asset, seeking to join the Main Market (Standard) The Company intends to focus on opportunities in the natural resources sector, raising gross proceeds of £830k. Due 28 Jan. Artemis Resources ltd, an ASX listed mining
Companies: STAF CASP EKF SAR LTG ERGO EDR BARK
Continued strong trading means FY21 results will be ahead of upgraded expectations. Trading in the core business is reported to be robust and demand has persisted for the group’s sample collection devices through to the end of the year. Further investment is expected in FY22 to drive core business growth, which remains a key strategic objective for the new management team. Last week’s announcement of a strategic partnership with Yourgene will help broaden the offering and underpin future growth
Companies: EKF Diagnostics Holdings plc
Companies: Medica Group Plc
Belluscura has released another very encouraging trading update and we again raise our production and revenue forecasts. The group sold 377 XPLO2R units in 2021, which was 25% higher than our forecast and well over double our initial estimate. Demand is strong and we raise our unit sales estimate for 2022 to 4,000 (was 3,000) and roll this through to 2023 and 2024. Belluscura has recognised the global supply chain challenges and has increased inventory levels of key components to pre-empt any di
Companies: Belluscura PLC
Creo Medical has announced the signing of Heads of Terms (HoTs) with a number of third-parties in fields such as laparoscopic surgery, robotically assisted surgery, and non-thermal plasma sterilisation. This announcement is in-line with Creo's three-tiered strategy of Build, Buy and Partner, demonstrating progress on the third tier through partnering with established, multi-national players in adjacent markets in order to maximise the potential of the core Creo technology. The HoTs relate to Cre
Companies: Creo Medical Group Plc
Joiners: No Joiners Today. Leavers: No Leavers Today. What’s cooking in the IPO kitchen? Strip Tinning Holdings, an established supplier of specialist connectors to the automotive sector, intends to join AIM. Strip Tinning manufactures specialist flexible electrical connectors related primarily to heating and antennae systems embedded within automotive glazing and to the connection of the cells within electric vehicle (EV) battery packs, increasingly using flexible and lightweight printed circui
Companies: CPP D4T4 DEMG EEE FPO KAT REVB XPF
A very good H1 update from CVS this morning. Sales growth is reported at 11.4% with LFL’s of c.10%, EBITDA up a strong 15.5% and H2 has got off to a good start. In short, another period of excellent delivery. We push through a 3.5% EPS upgrade for the current year and tick up outer year forecasts by 2%. The stage one deadline for the CMA to report on the Quality Pet Care deal is 18th Feb’22. There are a range of theoretical outcomes (no case to answer, divest some of the 8 practices, or divest a
Companies: CVS Group plc
What’s cooking in the IPO kitchen? Strip Tinning Holdings, an established supplier of specialist connectors to the automotive sector, intends to join AIM. Strip Tinning manufactures specialist flexible electrical connectors related primarily to heating and antennae systems embedded within automotive glazing and to the connection of the cells within electric vehicle (EV) battery packs, increasingly using flexible and lightweight printed circuit technology that also has growing application elsewhe
Companies: PGH IDE FNTL CZA ADME CCS CVSG EYE
Where next for markets in 2022? In our view, if COVID is not on the way out, we are just going to have to live with it now and it will have less and less impact on economic forecasts going forward. Instead, the bigger issues for investors to deal with in 2022 are cost inflation and staff shortages for business (which are already hitting earnings momentum), energy cost inflation and higher taxes hitting the consumer wallet, and markets that start from very elevated valuation multiples compared wi
Companies: GML HAT IOG LOK MTC QTX SOM SCE SNG TRCS TRMR
OptiBiotix has published a third human volunteer study on the cholesterol lowering effects of the company's proprietary probiotic Lactobacilus plantarum, branded as LPLDL. We believe the study clearly demonstrates the cholesterol lowering effect of LPLDL which we expect to support the on-going commercialisation of the probiotic. Key results were the statistically significant reduction in total cholesterol and LDL (bad) cholesterol of 34.2% and 28.4%, respectively over a six-week treatment period
Companies: OptiBiotix Health PLC
Joiners: No Joiners Today. Leavers: Charles Stanley Group has left the Main Market following a takeover by Raymond James UK Wealth Management Holdings. What’s cooking in the IPO kitchen? Artemis Resources ltd, an ASX listed mining exploration and development company intends to join AIM. The Company owns projects based in the Pilbara region of Western Australia, the Greater Carlow Gold-Copper-Cobalt Project in the West Pilbara and the Paterson Central exploration project in the East Pilbara. The
Companies: TST BIG CFCP CREO CSSG MIRI ORCP
Interim results to 30 September were marked by a return to pre-pandemic sales levels for the core business, with revenues rising 81% to £5.7m, which included c.£1.2m of COVID-related revenues. An adjusted EBITDA loss of £2.4m reflected the incremental costs of gearing up to supply the DHSC with COVID-19 antigen tests, which did not materialise. With the contract with DHSC now having expired, focus turns to other commercial opportunities. The core Health & Nutrition EBITDA of £1.15m covered the c
Companies: Omega Diagnostics Group PLC
We believe the narrative for the UK equity market remains very good. Some inflation appears embedded in markets and economic growth seems robust. We saw investors show caution into the end of 2021 and so have cash to deploy in our view. This has been corroborated by investor feedback we’ve had already this year. The UK equity market is materially cheaper than global equities on a relative basis so asset allocators have to be looking at UK equities while UK 2022 GDP growth is likely the best of t
Companies: AFM ANX AXL CYAN GLAN MODE OBI MATD SEN SOM WSG
Benchmark Holdings’ FY21 and particularly its Q4 (July to September) results confirmed the strong recovery in the business, led by its nutrition business, that had been indicated in the October pre-close trading update. An improving outlook in its key shrimp market and good conditions in the salmon and sea bass/bream sectors underpins an upgrade of our financial forecasts for FY22 and beyond. With £20m raised via a placing, Benchmark is now in a stronger position to invest in capital expansi
Companies: Benchmark Holdings Plc
Companies: SourceBio International Plc
Share: